Great West Life Assurance Co. Can decreased its holdings in Evolent Health Inc (NYSE:EVH) by 46.9% during the third quarter, Holdings Channel.com reports. The firm owned 4,645 shares of the technology company’s stock after selling 4,109 shares during the period. Great West Life Assurance Co. Can’s holdings in Evolent Health were worth $33,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the company. CWM LLC increased its holdings in shares of Evolent Health by 20.0% in the 3rd quarter. CWM LLC now owns 401,826 shares of the technology company’s stock valued at $2,889,000 after purchasing an additional 66,987 shares during the period. Handelsinvest Investeringsforvaltning increased its holdings in shares of Evolent Health by 60.0% in the 3rd quarter. Handelsinvest Investeringsforvaltning now owns 200,000 shares of the technology company’s stock valued at $1,438,000 after purchasing an additional 75,000 shares during the period. Virginia Retirement Systems ET AL acquired a new position in shares of Evolent Health in the 3rd quarter valued at about $329,000. Peregrine Capital Management LLC increased its holdings in shares of Evolent Health by 36.1% in the 3rd quarter. Peregrine Capital Management LLC now owns 1,530,763 shares of the technology company’s stock valued at $11,006,000 after purchasing an additional 405,993 shares during the period. Finally, Riverbridge Partners LLC increased its holdings in shares of Evolent Health by 0.7% in the 3rd quarter. Riverbridge Partners LLC now owns 3,428,455 shares of the technology company’s stock valued at $24,651,000 after purchasing an additional 24,929 shares during the period. Institutional investors own 95.15% of the company’s stock.

EVH has been the subject of several recent research reports. Zacks Investment Research cut Evolent Health from a “buy” rating to a “hold” rating in a research note on Tuesday, August 6th. ValuEngine raised Evolent Health from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. Cowen set a $18.00 price target on Evolent Health and gave the company a “buy” rating in a research note on Wednesday, August 7th. Cantor Fitzgerald set a $16.00 price target on Evolent Health and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Finally, Piper Jaffray Companies boosted their price target on Evolent Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research note on Wednesday. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Evolent Health presently has a consensus rating of “Buy” and a consensus price target of $15.75.

Shares of NYSE EVH opened at $10.12 on Friday. The stock has a market cap of $676.14 million, a price-to-earnings ratio of -28.91 and a beta of 1.07. The business has a 50 day simple moving average of $7.62 and a 200 day simple moving average of $8.79. Evolent Health Inc has a 52 week low of $5.50 and a 52 week high of $26.96. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.39 and a current ratio of 1.39.

Evolent Health (NYSE:EVH) last announced its quarterly earnings results on Tuesday, November 5th. The technology company reported ($0.09) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.12) by $0.03. The business had revenue of $220.14 million during the quarter, compared to analysts’ expectations of $217.90 million. Evolent Health had a negative return on equity of 6.87% and a negative net margin of 15.02%. The firm’s quarterly revenue was up 46.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.04) EPS. On average, analysts predict that Evolent Health Inc will post -0.96 EPS for the current year.

In related news, Director Kenneth A. Samet bought 7,200 shares of the firm’s stock in a transaction on Thursday, August 15th. The stock was purchased at an average price of $7.04 per share, with a total value of $50,688.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Doug S. Aron bought 10,550 shares of the firm’s stock in a transaction on Wednesday, August 14th. The shares were bought at an average cost of $8.20 per share, with a total value of $86,510.00. Insiders own 4.50% of the company’s stock.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management.

Read More: Reverse Stock Split

Want to see what other hedge funds are holding EVH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evolent Health Inc (NYSE:EVH).

Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.